SHANGHAI, China
,
Jan. 6
/PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in
China
and
the United States
, today announced that Dr.
Ge Li
, the Company's Chairman and Chief Executive Officer, will present at the 28th Annual J.P. Morgan Healthcare Conference on
Tuesday, January 12, 2010
, at
4:00 pm Pacific Standard Time
.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The Company will broadcast its presentation. The public may access the broadcast through the Investor Relations section of the Company's web site: http://www.wuxiapptec.com .
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in
China
and
the United States
. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com .
For more information, please contact:
Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-201-585-2048
Email: [email protected]
Stephanie Liu (for the media)
WuXi PharmaTech (Cayman) Inc.
Tel: +86-21-5046-4362
Email: [email protected]
Web: http://www.wuxiapptec.com
SOURCE WuXi PharmaTech (Cayman) Inc.
Share this article